Home/Filings/4/0001628908-22-000100
4//SEC Filing

Shams Aammaad 4

Accession 0001628908-22-000100

CIK 0001628908other

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 5:50 PM ET

Size

5.1 KB

Accession

0001628908-22-000100

Insider Transaction Report

Form 4
Period: 2022-08-01
Shams Aammaad
Chief Accounting Officer
Transactions
  • Award

    Class A Common Stock

    2022-08-01+17,24736,884 total
Footnotes (3)
  • [F1]Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
  • [F2]Securities vest at a rate of 34% on August 1, 2023, and 33% on August 1, 2024, and August 1, 2025.
  • [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001815354

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:50 PM ET
Size
5.1 KB